Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs)

Hilde Stevens, Geertrui Van Overwalle, Bart Van Looy, Isabelle Huys
2015 Biotechnology law report  
doi:10.1089/blr.2015.29008.hs pmid:26396462 pmcid:PMC4574745 fatcat:m2f2wzgalrfodd3ydccmslci5y